Health Highlights: July 14, 2022
By Ernie Mundell HealthDay Reporter
No rise in methadone ODs in pandemic, supporting use as at-home treatment. COVID crisis forced many opioid treatment centers to close, but addicts safely took the treatment at home, a new study finds. Read more
FDA approves Novavax as 4th COVID-19 vaccine. The two-dose vaccine employs nanoparticle technology to trigger an immune response, so it might be seen as alternative to mRNA-based shots from Pfizer or Moderna, experts say. Read more
Pharmacies must fill prescriptions for abortion meds, feds say. Failing to do so risks violating federal civil rights law barring sex discrimination, the Biden administration said on Wednesday. Read more
Demand is overwhelming NYC's effort to roll out monkeypox vaccine. The appointment system aimed at streamlining access to the vaccine crashed in America's largest city, one of many places where supplies have been running out almost as soon as they arrive. Read more
Cancer drug might be powerful treatment against multiple sclerosis. The drug, rituximab, is already used "off-label" for MS and is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. Read more
Asthma drug fails as potential COVID treatment. Despite hopes that the medicine might help, researchers found "no evidence" that fluticasone kept folks with mild-to-moderate COVID out of the hospital. Read more
Was this page helpful?
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.